Page 2 - Us Life Sciences News Today

Global property giant Lendlease has reported a loss for the first half of $264 million as it moves to simplify the business and focus on its core operations of development, construction and funds management.

USA’s East Coast is home to some of the largest Pharmaceutical and Life Science organisations in the world, including companies such as Johnson and Johnson, Merck, Celgene, BMS and more. Some of the strongest talent in the Life Science industry can be found here, with many of the country’s leading educational ...

Global property giant Lendlease has reported a loss for the first half of $264 million as it moves to simplify the business and focus on its core operations of development, construction and funds management.

Global property giant Lendlease has reported a loss for the first half of $264 million as it moves to simplify the business and focus on its core operations of development, construction and funds management.

/PRNewswire/ -- Key Takeaways: Projected returns on investment in pharma R&D in 2021 have risen to 7 % from 2.7 %, the largest annual increase since the study...

/PRNewswire/ -- Key Takeaways: Projected returns on investment in pharma R&D in 2021 have risen to 7 % from 2.7 %, the largest annual increase since the study...

Schloss Nymphenburg: 200 Millionen Euro soll es kosten, die Erwartungen sind hoch: Es soll ein Museum von internationaler Strahlkraft werden.

THE Mayor of the city and county of Limerick has visited the site of a major construction project in Newcastle West. Last month, US Life Sciences firm Orte...

New lab development downtown prepares to grow Worcesters life science market

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials ADELAIDE, AUS, Apr 29, 2021 - (ACN Newswire) - Agilex Biolabs, Australias largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics, shared key ways to navigate the immunogenicity and biomarker requirements fo...